Logo-bi
Bioimpacts. 2015;5(1): 17-23. doi: 10.15171/bi.2015.05
PMID: 25901293        PMCID: PMC4401163

Original Research

Non-invasive serum fibrosis markers: A study in chronic hepatitis

Mohammadreza Abdollahi 1, Aliasghar Pouri 2 * , Morteza Ghojazadeh 2, Rasoul Estakhri 3, Mohammadhossein Somi 2

Cited by CrossRef: 28

1- Park Y, Kim B, Park J, Kim D, Ahn S, Han K, Han S, Jeon M, Heo J, Song K, Kim S. Gamma‐glutamyl transpeptidase‐to‐platelet ratio is an independent predictor of hepatitis B virus‐related liver cancer. J of Gastro and Hepatol. 2017;32(6):1221 [Crossref]
2- Suarez-Quintero C, Patarroyo Henao O, Muñoz-Velandia O. Concordance between hepatic biopsy and the APRI index (Ast to Platelet Ratio Index) for the diagnosis of cirrhosis in patients with autoimmune liver disease. Gastroenterología y Hepatología (English Edition). 2021;44(7):465 [Crossref]
3- Sheptulina A, Shirokova E, Nekrasova T, Blum H, Ivashkin V. Platelet count to spleen diameter ratio non‐invasively identifies severe fibrosis and cirrhosis in patients with autoimmune hepatitis. J of Gastro and Hepatol. 2016;31(12):1956 [Crossref]
4- Yue W, Li Y, Geng J, Wang P, Zhang L. Aspartate aminotransferase to platelet ratio can reduce the need for transient elastography in Chinese patients with chronic hepatitis B. 2019;98(49):e18038 [Crossref]
5- Suarez-Quintero C, Patarroyo Henao O, Muñoz-Velandia O. Concordancia entre el resultado de la biopsia hepática y el índice APRI (Ast to Platelet Ratio Index) en el diagnóstico de cirrosis en pacientes con enfermedad hepática autoinmune. Gastroenterología y Hepatología. 2021;44(7):465 [Crossref]
6- Dong Y, Potthoff A, Klinger C, Barreiros A, Pietrawski D, Dietrich C. Ultrasound findings in autoimmune hepatitis. WJG. 2018;24(15):1583 [Crossref]
7- Ke M, Zhang M, Su Q, Wei S, Zhang J, Wang Y, Wu R, Lv Y. Gamma-glutamyl transpeptidase to platelet ratio predicts short-term outcomes in hepatocellular carcinoma patients undergoing minor liver resection. Journal of Surgical Research. 2018;231:403 [Crossref]
8- Li S, Cao D, He J, Lou M, Tu X, Li Y. High platelet count predicts poor prognosis in HCC patients undergoing TACE: a propensity score-matched analysis. Expert Review of Gastroenterology & Hepatology. 2022;16(2):193 [Crossref]
9- Wan M, Xu H, Li D, Wang L, Li X. Accuracy of gamma-glutamyl transpeptidase-to-platelet ratio (GPR), red cell distribution width (RDW), aspartate aminotransferase-to-platelet ratio index (APRI), and the fibrosis-4 index (FIB4) compared with liver biopsy in patients with drug-induced liver injury (DILI). 2021;100(6):e24723 [Crossref]
10- Wang B, Li F, Cheng L, Zhan Y, Wu B, Chen P, Shen J, Wu W, Ma X, Zhu J, Pan B, Guo W, Cheng Y. The Pretreatment Platelet Count is an Independent Predictor of Tumor Progression in Patients Undergoing Transcatheter Arterial Chemoembolization with Hepatitis B Virus-Related Hepatocellular Carcinoma. Future Oncol. 2019;15(8):827 [Crossref]
11- Chen H, Shen Y, Wu S, Zhu Q, Weng C, Zhang J, Wang M, Jiang W. Diagnostic role of transient elastography in patients with autoimmune liver diseases: A systematic review and meta-analysis. World J Gastroenterol. 2023;29(39):5503 [Crossref]
12- Wang L, Wu Z, Wang A, Jin X, Qiu Y. Effects of nucleo(s)tide analogs therapy on chronic hepatitis B as evaluated by hepatosplenic radionuclide angiography. 2020;41(4):314 [Crossref]
13- Shahramian I, Khalili M, Sargazi A, Dechal A, Bazi M, Jahantigh M, Delaramnasab M, Bazi A. Non-Invasive Markers of Liver Fibrosis in Children with Chronic Hepatic Disorders. Gene Cell Tissue. 2020;7(3) [Crossref]
14- Turner B, Liang Y, Singal A. FIB-4 and imaging for measuring fibrosis in hepatitis C virus. 2017;29(2):192 [Crossref]
15- Park S, Choi N. Hepatitis virus infection and age-related cataract. Sci Rep. 2017;7(1) [Crossref]
16- Anastasiou O, Büchter M, Baba H, Korth J, Canbay A, Gerken G, Kahraman A. Performance and Utility of Transient Elastography and Non-Invasive Markers of Liver Fiibrosis in Patients with Autoimmune Hepatitis: A Single Centre Experience. Hepat Mon. 2016;16(11) [Crossref]
17- Moosavy S, Eftekhar E, Davoodian P, Nejatizadeh A, Shadman M, Zare S, Nazarnezhad M. AST/ALT ratio, APRI, and FIB-4 compared to FibroScan for the assessment of liver fibrosis in patients with chronic hepatitis B in Bandar Abbas, Hormozgan, Iran. BMC Gastroenterol. 2023;23(1) [Crossref]
18- Musa Y, Abdulkadir Y, Ibrahim Y, Maiyaki A, Yakubu A, Ijeoma I, Samaila A, Muhammad M. Hepatic fibrosis among chronic hepatitis B virus-infected patients: North-Western Nigeria experience. Niger J Gastroenterol Hepatol. 2024;16(1):8 [Crossref]
19- Dong H, Xu C, Zhou W, Liao Y, Cao J, Li Z, Hu B. The combination of 5 serum markers compared to FibroScan to predict significant liver fibrosis in patients with chronic hepatitis B virus. Clinica Chimica Acta. 2018;483:145 [Crossref]
20- Liu L, Cao J, Zhong Z, Guo Z, Jiang Y, Bai Y, Xu J. Noninvasive indicators predict advanced liver fibrosis in autoimmune hepatitis patients. Clinical Laboratory Analysis. 2019;33(7) [Crossref]
21- Nan Y, Niu X, Wang R, Zhao S, Fu N, Du J, Wang Y, Wang B, Zhang Y. microRNA‑1273g‑3p is a useful non‑invasive test for the prediction of liver fibrosis in patients with chronic hepatitis C. Exp Ther Med. 2018; [Crossref]
22- Zaman B, Rasool S, Merza M, Abdulah D. Hepcidin-to-ferritin ratio: A potential novel index to predict iron overload-liver fibrosis in ß-thalassemia major. Transfusion Clinique et Biologique. 2022;29(2):153 [Crossref]
23- Xu X, Jiang L, Wu C, Pan L, Lou Z, Peng C, Dong Y, Ruan B. The role of fibrosis index FIB-4 in predicting liver fibrosis stage and clinical prognosis: A diagnostic or screening tool?. Journal of the Formosan Medical Association. 2022;121(2):454 [Crossref]
24- Wong S, Huynh D, Zhang F, Nguyen N. Use of aspartate aminotransferase to platelet ratio to reduce the need for FibroScan in the evaluation of liver fibrosis. WJH. 2017;9(17):791 [Crossref]
25- Lemoinne S, Heurgue A, Bouzbib C, Hanslik B, Gournay J, Nguyen-Khac E, Bureau C, de Lédinghen V, Ganne-Carrié N, Bourlière M. Non-invasive diagnosis and follow-up of autoimmune hepatitis. Clinics and Research in Hepatology and Gastroenterology. 2022;46(1):101772 [Crossref]
26- Drees J, Wi S, Ready J, Dlott R, Fetterman B, Seo S, Pat Pauly M, Petrie M, Lorey T. Serum Fibrosis Marker Panels FIB-4 Index and Aspartate Aminotransferase (AST)-to-Platelet Ratio Index (APRI) Are Equivalent to AST Alone at Predicting Liver Fibrosis in a Cohort of 1731 Patients Infected with Hepatitis C Virus. 2017;2(1):76 [Crossref]
27- Sheptulina A, Shirokova E, Ivashkin V. Non-invasive methods for diagnostics of liver fibrosis in patients with autoimmune hepatitis and autoimmune hepatitis - primary biliary cirrhosis. Klin med. 2017;94(11):843 [Crossref]
28- Ben Ayed H, Koubaa M, Yaich S, Rekik K, Ben Jemaa T, Maaloul I, Marrekchi C, Damak J, Ben Jemaa M. A new combined predicting model using a non-invasive score for the assessment of liver fibrosis in patients presenting with chronic hepatitis B virus infection. Médecine et Maladies Infectieuses. 2019;49(8):607 [Crossref]
29- Fan R, Li G, Yu N, Chang X, Arshad T, Liu W, Chen Y, Wong G, Jiang Y, Liang X, Chen Y, Jin X, Dong Z, Leung H, Wang X, Zeng Z, Yip T, Xie Q, Tan D, You S, Ji D, Zhao J, Sanyal A, Sun J, Zheng M, Wong V, Yang Y, Hou J. aMAP Score and Its Combination With Liver Stiffness Measurement Accurately Assess Liver Fibrosis in Chronic Hepatitis B Patients. Clinical Gastroenterology and Hepatology. 2023;21(12):3070 [Crossref]

As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge